We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

iCAD

Offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid an... read more Featured Products: More products

Download Mobile App




AI Improves Efficiency and Accuracy of Breast Cancer Imaging

By HospiMedica International staff writers
Posted on 12 Aug 2019
Artificial intelligence (AI) can help shorten digital breast tomosynthesis (DBT) reading time while maintaining or improving accuracy, claims a new study.

Researchers at the University of Pennsylvania (UPENN: Philadelphia, PA, USA), iCAD (Nashua, NH, USA), and other institutions have developed a deep learning AI system that is capable of identifying suspicious soft-tissue and calcified lesions in DBT images. More...
The system was trained on a large DBT data set, following which its performance was tested by having 24 radiologists, including 13 breast subspecialists, each read 260 DBT examinations with and without AI assistance. The examinations included 65 cancer cases.

The results revealed that radiologist performance for the detection of malignant lesions increased from 0.795 without AI to 0.852 with AI, while reading time decreased by 52.7%, from 64.1 seconds without to 30.4 seconds with AI. Sensitivity increased from 77% without AI to 85% with AI, specificity increased from 62.7% without to 69.6% with AI, and recall rate for non-cancers decreased from 38% without to 30.9% with AI. The study was published on July 31, 2019, in Radiology: Artificial Intelligence.

“Overall, readers were able to increase their sensitivity by eight percent, lower their recall rate by seven percent, and cut their reading time in half when using AI concurrently while reading DBT cases,” said lead author Professor Emily Conant, MD, chief of breast imaging at UPENN. “The concurrent use of AI with DBT increases cancer detection, and may bring reading times back to about the time it takes to read digital mammography alone.”

DBT acquires multiple images over a limited angular range to produce a set of reconstructed images, which can then be viewed individually or sequentially in a cine loop, and in a 3D image of the breast, which can viewed in narrow slices, similar to CT scans. While in conventional 2D mammography overlapping tissues can mask suspicious areas, 3D images eliminate the overlap, making abnormalities easier to recognize. It is estimated that 3D DBT will replace conventional mammography within ten years.


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.